Stock ORPHA ORPHAZYME A/S
Add to a list
To use this feature you must be a member
Log inSign up

Sector Chart Orphazyme A/S

Equities

ORPHA

DK0062502894

Market Closed - Nasdaq Copenhagen
Other stock markets
 11:20:00 2024-07-12 EDT 		5-day change 1st Jan Change
900.1 DKK -1.52% Intraday chart for Orphazyme A/S -4.24% -32.32%
03-27 Orphazyme A/S Reports Earnings Results for the Full Year Ended December 31, 2023 CI
03-04 FDA Extends Review of Zevra's Arimoclomol by Three Months DJ
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes

Sector Bio Therapeutic Drugs

Capi. Sales growth Profitability Finances EV / Sales P/E ratio
ORPHAZYME A/S Stock Orphazyme A/S
 4.65M - - - - -
VERTEX PHARMACEUTICALS INCORPORATED Stock Vertex Pharmaceuticals Incorporated
 126B
REGENERON PHARMACEUTICALS, INC. Stock Regeneron Pharmaceuticals, Inc.
 119B
ARGENX SE Stock argenx SE
 27.95B -
BIONTECH SE Stock BioNTech SE
 20.5B -
GENMAB A/S Stock Genmab A/S
 17.12B
  1. Stock Market
  2. Equities
  3. ORPHA Stock
  4. Charts Orphazyme A/S
  5. Sector Chart